Kura Oncology’s fair value estimate has been adjusted from US$32.27 to US$31.08, a small move that still reflects detailed ...

The systemic lupus erythematosus (SLE) market continues to evolve toward biologic-driven care, with increasing treatment complexity, intensifying competition among advanced therapies, and a robust ...

Twenty-seven years ago today, a Broadway legend who also wrote a long list of hit songs died of cancer in Florida.

Greta Garbo was a silent film star during the golden era of Hollywood. She was ranked No. 5 on the American Film Institute’s ...

Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare ...

Akebia Therapeutics’ fair value target is held at US$4.40 per share, with the latest model keeping this figure steady versus the prior view. That lack of movement comes even as analysts debate the ...

A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...

External Affairs Minister S. Jaishankar's visit to Mauritius has delivered a series of impactful outcomes across health, ...

Unicycive Therapeutics, Inc. (UNCY) 25th Annual Needham Virtual Healthcare Conference April 15, 2026 3:45 PM EDTCompany ParticipantsShalabh Gupta - ...

Speaking during a joint launch of projects and exchange of MoUs with Mauritius Prime Minister Navinchandra Ramgoolam, as part of his two-day visit to the country, Jaishankar highlighted the deepening ...

AstraZeneca is driven by a diversified portfolio, robust R&D, and strong FCF, despite a current valuation that is slightly ...

Real-world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day 28, for patients infected with highly resistant metallo-beta lactamase ...